Zofran Birth Defect Legal News Articles & Interviews

Washington, DC: Families of patients who allegedly suffered birth defects while taking GlaxoSmithKline’s (GSK) anti-nausea drug Zofran, and who are suing the drug maker in multi-district litigating (MDL) are asking that the drug maker hand over data stored in a drug safety database called “Argus.”

Houston, TX: Another Zofran lawsuit filed by parents in Texas joins more than 300 suits filed nationwide against the manufacturer. Most all federal cases consolidated into a multidistrict litigation in Massachusetts are making progress and a first trial date is expected soon.

Birmingham, AL: Many women who took Zofran during their pregnancy had idea that it is prescribed “off-label”, meaning it wasn’t approved by the FDA to treat morning sickness.

Hattiesburg, MS: “Getting money from the Zofran class-action lawsuit isn’t as important to me as getting the word out to the public about how dangerous this drug is,” says Lucy. Her daughter was born with clubfoot, a birth defect associated with Zofran.

Pittsburgh, PA: While Zofran birth defects lawsuits continue to be filed, a recent study has not found a link between the anti-nausea drug and birth defects.

Los Angeles, CA: A new study conducted by researchers at UCLA suggests there is no link between Zofran and birth defects. The study comes as more women are filing lawsuits alleging their infants suffered serious Zofran side effects after exposure in the womb. It also contradicts previous research that suggested a link between the anti-nausea medication and birth defects. Among the side effects alleged in the Zofran lawsuits are an increased risk of heart defects and cleft palate.

Bethpage, NY:When Laura’s son was born with hypospadias, she had no idea that the birth defect could be caused by Zofran. “If nothing comes of my Zofran complaint I want to tell my story to help prevent this happening to another child,” says Laura.

Toronto, ON: Women in Canada have filed lawsuits alleging their babies developed birth defects after being exposed to Zofran (known generically as ondansetron). Similar to lawsuits filed in the United States, lawsuits in Canada allege women were given Zofran to treat nausea and vomiting linked to morning sickness, even though Zofran was not approved to treat pregnant women.

Boston, MA: Plaintiffs involved in Zofran lawsuits, including multidistrict litigation (MDL 2657), have discovered that Zofran labeling in Canada warns against the use of the anti-nausea drug during pregnancy because of possible birth defects. The US label has no such warning. According to plaintiffs, this means that Canadian mothers were warned that Zofran may harm their babies when taken during pregnancy, but mothers in the United States were not.

Pittsburgh, PA: GlaxoSmithKline faces more Zofran lawsuits alleging babies developed birth defects after being exposed to Zofran in the womb. While some women say their children have outgrown the Zofran side effects, others say the effects have lasted well into their child's life, and traumatized their families. With lawsuits consolidated for pretrial proceedings, more parents are filing claims against the maker of Zofran, saying they would never have exposed their unborn babies to the drug if they had known about the risks.